Endocrine
1924 — Seale Harris's paper in the Journal of the American Medical Association describing spontaneous hyperinsulinism
Reactive hypoglycemia, historically described as a condition in which blood sugar fell to low levels in the hours following food intake, occupied a complicated and contested place in twentieth-century medicine. Physicians debated for decades whether the phenomenon represented a genuine pathological entity or an artifact of measurement and interpretation. The history of its understanding was inseparable from the broader story of insulin discovery and the development of blood glucose testing.
Historical Narrative
Before the isolation of insulin in the early twentieth century, the concept of blood sugar regulation was poorly understood, and conditions related to abnormal glucose metabolism were interpreted through frameworks centered on digestion, nervous exhaustion, and constitutional weakness. Nineteenth-century physicians who encountered patients complaining of weakness, faintness, and trembling in the hours after meals often attributed these episodes to dyspepsia, neurasthenia, or disorders of the stomach and liver. The German physician Carl von Noorden, who conducted extensive research on metabolic diseases in the late nineteenth and early twentieth centuries, contributed foundational descriptions of carbohydrate metabolism disorders, providing a scientific vocabulary that later researchers would build upon.
The isolation of insulin by Frederick Banting and Charles Best in 1921 at the University of Toronto transformed the study of blood sugar disorders entirely. Within a few years of insulin's discovery, physicians recognized that abnormally low blood glucose could occur in certain patients without deliberate insulin administration. Seale Harris, an American physician practicing in Birmingham, Alabama, published a landmark paper in the Journal of the American Medical Association in 1924 in which he described patients who appeared to experience spontaneous episodes resembling insulin overdose. Harris proposed that the pancreas in certain individuals secreted excessive insulin in response to food, causing blood sugar to fall to symptomatic levels after meals. He named this phenomenon hyperinsulinism and advocated for dietary modification as the historical response.
Harris's observations sparked significant clinical interest throughout the 1920s and 1930s. Physicians in North America and Europe began identifying and categorizing patients who reported episodic distress occurring in the postprandial period, and the glucose tolerance test became the primary investigative tool. This test, in which blood glucose was measured at intervals following a standardized dose of glucose, was used to document the characteristic fall in blood sugar that Harris and colleagues associated with the condition.
Through the mid-twentieth century, the concept attracted considerable popular attention, partly because it seemed to explain a wide variety of vague complaints. Books directed at lay audiences in the 1950s and 1960s promoted the idea that unrecognized low blood sugar was a widespread and underdiagnosed cause of fatigue, irritability, and other symptoms, leading to a period in which the diagnosis was applied very broadly. This popularization created tension within the medical community, and by the 1970s, major professional organizations including the American Diabetes Association and the Endocrine Society issued joint statements cautioning that the condition was being overdiagnosed and that the glucose tolerance test alone was an insufficient basis for clinical conclusions.
Researchers including Gerald Reaven at Stanford University contributed to more rigorous investigations of insulin secretion dynamics and postprandial glucose patterns in the latter decades of the twentieth century, helping to distinguish genuine reactive hypoglycemia from other metabolic phenomena. The history of this condition illustrated how the development of laboratory technology, particularly blood glucose measurement, could simultaneously open new diagnostic possibilities and create new controversies about the boundaries of disease.
Key Historical Figures
Historical narrative only — this page describes how Reactive hypoglycemia was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.